Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04086082 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging

Study acronym: MAGIK
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 2024 to Dec 2028v7
  2. Trial status: Not Yet Recruiting to Recruitingv6 Show 4 more changesShow less
    • Primary completion date: Jul 2022 to Dec 2024
    • Start date changed from estimate of Mar 2022 to May 24, 2023
    • Study sites: 0 to 1
    • Study completion date: Jul 2027 to Dec 2028
  3. Start date: Jul 2021 to Mar 2022v5
  4. Primary completion date: Jun 2021 to Jul 2022
    • Start date: Jan 2020 to Jul 2021
    • Study completion date: Jun 2026 to Jul 2027
    v4
  5. Start date: Oct 2019 to Jan 2020v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Sydney
35 trials monitored
See 1 trial at risk
Lung Cancer
4,790 trials monitored
See 263 trials at risk
This trial will investigate the feasibility of the Markerless Tumour Tracking technology.
Trial Details
NCT Number NCT04086082
Lead Sponsor University of Sydney
Conditions
(from sponsor)		 Lung Cancer
Related terms Lung Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov